Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01119524
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PNN | PENICILLIN G | A,B | 1GM7 | 0.73 |  |
| PNN | PENICILLIN G | B | 1FXV | 0.73 | |
| PNN | PENICILLIN G | A | 1UOF | 0.73 | |
| PNN | PENICILLIN G | A | 1UOB | 0.73 | |
PN1 | (2S,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A | 1W2N | 0.75 | |
| PN1 | (2S,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A | 1UNB | 0.75 | |
PNM | OPEN FORM - PENICILLIN G | A | 1GHP | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1PWC | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1IYQ | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1FQG | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2J8Y | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2JBF | 0.72 | |
| PNM | OPEN FORM - PENICILLIN G | A | 2EX8 | 0.72 | |
CLS | CEPHALOTHIN | A,B | 1KVL | 0.77 | |
PG1 | PENICILLIN G ACYL-SERINE | A,B | 1XA7 | 0.73 | |
| PG1 | PENICILLIN G ACYL-SERINE | A | 2IWC | 0.73 | |
| PG1 | PENICILLIN G ACYL-SERINE | A,B | 1MWT | 0.73 | |
G23 | (2R,4S)-2-[(R)-BENZYLCARBAMOYL- PHENYLACETYL-METHYL]-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | A | 1HTE | 0.73 | |
ICX | methyl N-[(5Z)-6-({[4-(4-iodobenzyl)phenyl]carbonyl}amino)hex- 5-enoyl]glycinate | A,C,D,E,G,P, Q,R,W | 3CWB | 0.7 | |
LOR | LORACABEF | A,B | 1FCN | 0.76 | |
CFX | CEFOXITIN | A,B | 1YMX | 0.72 | |
| CFX | CEFOXITIN | A,B | 1I2W | 0.72 | |
ENB | ETHYL (2E,4S)-4-[((2R)-2-{[N-(TERT- BUTOXYCARBONYL)-L-VALYL]AMINO}- 2-PHENYLETHANOYL)AMINO]-5-[(3S)- 2-OXOPYRROLIDIN-3-YL]PENT-2-ENOATE | A,B | 2D2D | 0.71 | |
DBZ | 3-(BENZOYLAMINO)-L-ALANINE | A,B,C,D | 1SN9 | 0.7 | |
| DBZ | 3-(BENZOYLAMINO)-L-ALANINE | A,B | 1SNE | 0.7 | |
| DBZ | 3-(BENZOYLAMINO)-L-ALANINE | A,B,C,D | 1SNA | 0.7 | |
| DBZ | 3-(BENZOYLAMINO)-L-ALANINE | A,B | 1XOF | 0.7 | |
CEH | 5-{3-(S)-(4-(R)-ACETYLAMINO-4-CARBOXY- BUTYRYLAMINO)-3-[1-(R)-(1-(R)-CARBOXY- ETHYLCARBAMOYL)-ETHYLCARBAMOYL]- PROPYL}-2-(CARBOXY-PHENYLACETYLAMINO- METHYL)-3,6-DIHYDRO-2H-[1,3]THIAZINE- 4-CARBOXYLIC ACID | A | 1HVB | 0.73 | |
TIN | A,B | 1N94 | 0.72 | | |
SOX | N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)- 4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~- THIA-1-AZABICYCLO[3.2.0]HEPT-6- YL]-2-PHENYLACETAMIDE | B | 1GM8 | 0.72 | |
| SOX | N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)- 4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~- THIA-1-AZABICYCLO[3.2.0]HEPT-6- YL]-2-PHENYLACETAMIDE | A,B | 1GM9 | 0.72 | |
AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A | 2RDD | 0.75 | |
| AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A,B,C,D | 1NX9 | 0.75 | |
| AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A | 1H8S | 0.75 | |
| AIC | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLIC ACID | A | 2EX6 | 0.75 | |